XML 26 R12.htm IDEA: XBRL DOCUMENT v3.25.1
SUPPLEMENTAL FINANCIAL INFORMATION
 3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
SUPPLEMENTAL FINANCIAL INFORMATION SUPPLEMENTAL FINANCIAL INFORMATION
Allowance for Doubtful Accounts
The following table is a summary of the changes in our allowance for doubtful accounts for the three months ended March 31, 2025 and 2024.
Three Months Ended March 31,
(in millions)20252024
Balance at beginning of period$71 $62 
Charged to costs and expenses(4)(1)
Write-offs(2)(3)
Currency translation adjustments1 (2)
Balance at end of period$66 $56 
Inventories
(in millions)March 31,
2025		December 31,
2024
Raw materials$550 $510 
Work in process310 266 
Finished goods1,310 1,270 
Inventories$2,170 $2,046 
Property, Plant and Equipment, Net
(in millions)March 31,
2025		December 31,
2024
Property, plant and equipment, at cost$7,431 $7,648 
Accumulated depreciation(4,714)(4,778)
Property, plant and equipment, net$2,717 $2,870 
Other Current Assets and Liabilities
In connection with the sale of our Kidney Care business and pursuant to the EPA, the Kidney Care assets and liabilities in certain countries are to be transferred at a later date for operational, regulatory or other reasons. Accordingly, the related assets, primarily consisting of accounts receivable, of $95 million and liabilities, consisting of accounts payable, of $7 million of these deferred markets and are presented within prepaid and other current assets and accrued expenses and other current liabilities in the accompanying condensed consolidated balance sheet as of March 31, 2025.
In the first quarter of 2025, we signed a purchase agreement with a buyer to sell our manufacturing facility in Opelika, Alabama for $25 million, subject to the satisfaction of various closing conditions. The related assets are classified as held-for-sale and are presented within prepaid and other current assets in the accompanying condensed consolidated balance sheet as of March 31, 2025. While the closing remains subject to the satisfaction of various closing conditions, we currently expect the transaction to close in 2025 and the net book value of the assets as of March 31, 2025 approximates the transaction price net of estimated selling costs.
Interest Expense, Net
Three Months Ended March 31,
(in millions)20252024
Interest expense, net of capitalized interest$81 $103 
Interest income(17)(25)
Interest expense, net$64 $78 
Other (Income) Expense, Net
Three Months Ended March 31,
(in millions)20252024
Foreign exchange losses, net$— $14 
Pension and other postretirement benefit plans(11)(13)
Change in fair value of marketable equity securities1 (3)
Equity method investment impairment9 — 
Other, net(2)(7)
Other (income) expense, net$(3)$(9)
Non-Cash Operating and Investing Activities
Right-of-use operating lease assets obtained in exchange for lease obligations for the three months ended March 31, 2025 and 2024 were $5 million and $16 million, respectively.
Purchases of property, plant and equipment included in accounts payable as of March 31, 2025 and 2024 were $39 million and $35 million, respectively.